1. Home
  2. TCMD vs IMRX Comparison

TCMD vs IMRX Comparison

Compare TCMD & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

N/A

Current Price

$28.78

Market Cap

300.1M

Sector

Health Care

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$5.60

Market Cap

322.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCMD
IMRX
Founded
1995
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.1M
322.8M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
TCMD
IMRX
Price
$28.78
$5.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$36.00
$17.20
AVG Volume (30 Days)
401.4K
639.7K
Earning Date
05-19-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
17.14
37.75
EPS
0.82
N/A
Revenue
N/A
N/A
Revenue This Year
$11.60
N/A
Revenue Next Year
$9.14
N/A
P/E Ratio
$35.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.61
$1.10
52 Week High
$37.77
$10.08

Technical Indicators

Market Signals
Indicator
TCMD
IMRX
Relative Strength Index (RSI) 49.47 59.64
Support Level $26.47 $5.34
Resistance Level $30.92 $7.67
Average True Range (ATR) 1.74 0.28
MACD 0.00 0.07
Stochastic Oscillator 16.11 89.88

Price Performance

Historical Comparison
TCMD
IMRX

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: